Clinical trial · Interventional
The Effects of Acupressure on Improving Postoperative Gastrointestinal Symptom Distress in Esophageal Cancer Patients
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study is a quasi-experimental design clinical trial with the primary objective of comparing the health status of patients with esophageal cancer. Participants were divided into an experimental group and a control group. Patients in the experimental group received routine care and acupressure for 5 consecutive days starting from the day after entering the ward after esophageal cancer surgery, in the control group, participants received routine care, and Participants were assessed on the Gastrointestinal Symptom Distress Scale at the end of the intervention. The aim of this study was to verify the effectiveness of acupressure in improving of gastrointestinal symptoms distress after esophageal cancer surgery.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Esophageal Cancer | Malignant Esophageal Neoplasm | CURATED_EXACT | 0.92 |
| Gastrointestinal Dysfunction | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| acupressure | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- acupressure
- description
- Participants received routine care and acupressure.
- interventionNames
- Other: acupressure
- type
- NO_INTERVENTION
- label
- no intervision
- description
- received routine care
Primary outcomes (1)
- measure
- Change from Baseline in gastrointestinal symptom distress Scale at study day 5(end day)
- timeFrame
- Baseline and study day 5
- description
- The Gastrointestinal Symptom Distress Scale is a validated self-report tool that assesses 10 gastrointestinal symptoms that patients with esophageal cancer may face after surgery. The 10-question questionnaire measures the self-perceived severity of nausea, vomiting, satiety, bloating, abdominal cramps, acid reflux, chest tightness, heart burn, diarrhea, and constipation, as well as the degree of interference with life. Using an 11-point Likert scale, 0 points (never happened), 1 point (very slight/very slight interference), 10 points (very severe/extreme interference), and the total score of the scale is 0-100 points. The higher the measured score, the more severe the gastrointestinal discomfort symptoms are and the more they interfere with life. The Gastrointestinal Symptom Distress Scale was subjected to an expert validity review, using the CVI (content validity index) calculation method, and the score was above 0.80.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 85 Years
Show eligibility criteria text
Inclusion Criteria: * Hospitalized men and women who agree to participate in this study * Patients diagnosed with esophageal cancer based on pathological tissue section results * Nutritional support through jejunostomy in post esophagectomy patients * A sufficient level of education to understand study procedures and be able to communicate with site personnel Exclusion Criteria: * Pregnant or lactating women * Diagnosed and treated for peripheral vascular disease within 3 months prior to surgery. * Those with unstable vital signs and septicemia infection after surgery. * Those who are suffering from blood diseases with abnormal coagulation function, or Currently taking anticoagulant drugs.
References
Publications (0)
Data not yet available